News & Events

Calendar of Events

Upcoming seminar and event information

Headshot of Dr. Ronald Crystal in lab coat

A gene therapy developed by Weill Cornell Medicine and NewYork-Presbyterian investigators helped slow progression of a rare and fatal genetic disorder in children called late infantile Batten...

Read More
Microscopic image of Ustilago maydis cells, the image shows that damaged telomeres can recruit a DNA repair protein.

Researchers at Weill Cornell Medicine have...

Read More
female physician talking to male patient

Patient mistrust of the healthcare system, which has come under new focus during the COVID-19 pandemic, is partly the result of an increasingly consumer-oriented healthcare system, according to a new commentary by a Weill Cornell Medicine investigator.

"Trust is the glue that holds all of healthcare together,” said lead author Dr. Dhruv Khullar, an assistant...

Read More
Dr. Kristen Marks

Hospitals in the U.S. began receiving the first COVID-19 vaccine on December 14 and vaccinating healthcare workers, in the first step of the biggest vaccination campaign in U.S. history. On December 11, the ...

Read More
3D illustration of coronary artery plaque

The risk of dying seven years after coronary artery bypass surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts, but there was no apparent...

Read More
Participants in Eighth Annual Appel Alzheimer's Disease Research Institute Symposium. Top, left to right: Dr. Matthew Fink, Dr. Bruce Miller, Dr. Anna Orr. Bottom, left to right: Dr. Jonathan Kipnis, Dr. Manu Sharma, Dr. Li Gan.

Investigators on...

Read More
Human pluripotent stem cell-derived alveolar organoid xenograft

Human organoids, tiny organ-like structures grown in...

Read More
Construction site of tents for overflow capacity for hospitals.

Researchers from Weill Cornell Medicine, Cornell University and San Jose State University have identified six free planning models for estimating hospital...

Read More
Image of a colon tumor in mice. Cancer-associated fibroblasts  help the tumor grow more aggressively and help block the immune system response against it.

Molecular changes in cells called fibroblasts, which help provide support for...

Read More
Dr. Roy Gulick leaning on desk in office

Weill Cornell Medicine has received a renewal of a prestigious ...

Read More
arm on couch with IV in hand

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorkers, according to a viewpoint article published in JAMA Oncology on Aug. 13 by Weill Cornell Medicine and NewYork-Presbyterian investigators. The authors write that higher rates of SARS-CoV-2 infection among Blacks and Hispanics will lead to delays...

Read More
Illustration of COVID-19 molecules and blood cells

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms? The multidisciplinary team will seek to identify underlying genetic and immune factors that contribute to these varying outcomes to help guide the development of precision prevention and treatment efforts.

The ...

Read More
Researcher looking at information on tablet in laboratory

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a ...

Read More
COVID-19 molecules

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The findings provide new insights into the relationship between viral load and the risk of severe illness in both populations and may help guide treatment decisions.

The researchers, whose ...

Read More
male physician testing older female blood pressure

New York, NY – NewYork Quality Care, the accountable care organization (ACO) of NewYork-Presbyterian, Columbia University Irving Medical Center, and Weill Cornell Medicine, saved Medicare $23,288,625 in 2019 and improved the quality of care for Medicare beneficiaries, according to performance results recently released by the Centers for Medicare & Medicaid Services (CMS). The three...

Read More
illustration of diversity

Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research. 

Investigators at Weill Cornell Medicine are leading three of the six projects, which range from $150,000 and $370,000 in...

Read More
COVID-19 molecule

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19, a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian has found. The findings suggest that in the absence of other risk factors for poor COVID-19 outcomes, patients with cancer may be able to safely continue treatment during the pandemic. It is important to weigh the risk of severe COVID-19 illness against the risk of delaying...

Read More
Medical stethoscope on a stack of paper.

Physicians who care for the most socially disadvantaged patients were more likely to receive lower scores in a Centers for Medicare & Medicaid Services (CMS) program that...

Read More

Government & Community Affairs 1300 York Ave., Box 314 New York, NY 10065